MEEDER ASSET MANAGEMENT INC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$409
-59.1%
22
-77.3%
0.00%
Q3 2022$1,000
-99.0%
97
-99.5%
0.00%
-100.0%
Q3 2021$99,000
-7.5%
18,5810.0%0.01%0.0%
Q2 2021$107,000
+25.9%
18,5810.0%0.01%
+25.0%
Q1 2021$85,000
+54.5%
18,581
-0.0%
0.00%0.0%
Q3 2020$55,000
-36.0%
18,5820.0%0.00%
-33.3%
Q2 2020$86,000
+65.4%
18,582
+35.2%
0.01%
+50.0%
Q1 2020$52,000
+108.0%
13,747
+111.8%
0.00%
+100.0%
Q4 2019$25,000
+31.6%
6,492
+91.4%
0.00%
+100.0%
Q3 2019$19,000
-62.0%
3,392
-74.4%
0.00%
-66.7%
Q2 2019$50,000
+455.6%
13,251
+678.1%
0.00%
+200.0%
Q1 2019$9,000
-86.6%
1,703
-95.0%
0.00%
-83.3%
Q4 2018$67,000
+45.7%
34,237
+185.1%
0.01%
+100.0%
Q3 2018$46,000
-99.9%
12,010
-27.3%
0.00%
-25.0%
Q2 2018$51,519,000
+1030280.0%
16,512
+614.2%
0.00%
Q1 2018$5,000
+66.7%
2,312
+125.3%
0.00%
Q4 2017$3,0001,0260.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders